CXCL8 and neoplasm: Furthermore, inhibition of ERK using U0126 partially blocked OA-induced ANGPTL4 expression but dramatically inhibited IL-8 and NOX4 expression, followed by the inhibition of tumor cell invasion (Figure S7C).